The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment
Open accessAbstract
Parkinson's disease (PD) is a neurodegenerative disease with a 200 year-long research history. Our understanding about its clinical phenotype and pathogenesis remains limited, although dopaminergic replacement therapy has significantly improved patient outcomes. Autonomic dysfunction is an essential category of non-motor phenotypes that has recently become a cutting edge field that directs frontier research in PD. In this review, we initially describe the epidemiology of dysautonomic symptoms in PD. Then, we perform a meticulous analysis of the pathophysiology of autonomic dysfunction in PD and propose that the peripheral autonomic nervous system may be a key route for α-synuclein pathology propagation from the periphery to the central nervous system. In addition, we recommend that constipation, orthostatic hypotension, urinary dysfunction, erectile dysfunction, and pure autonomic failure should be viewed as prodromal dysautonomic markers in PD prediction and diagnosis. Finally, we summarize the strategies currently available for the treatment of autonomic dysfunction in PD and suggest that high-quality, better-designed, randomized clinical trials should be conducted in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
Heart rate variability in leucine‐rich repeat kinase 2‐associated Parkinson's disease
Visanji, N. P., Bhudhikanok, G. S., Mestre, T., Ghate, T., Udupa, K., AlDakheel, A., Connolly, B. S., Gasca‐Salas, C., Kern, D. S., Jain, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.26896 · Cited by 24
Yalcin, A., Atmış, V., Cengiz, O., Çınar, E., Aras, S., Varlı, M., & Atlı, T. (2016) · Aging and Disease · doi:10.14336/ad.2015.0819 · Cited by 21
Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys
Shultz, J., Resnikoff, H., Bondarenko, V., Joers, V. L., Mejia, A. F., Simmons, H. A., & Emborg, M. E. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000279 · Cited by 21
Gastrointestinal complications in newly diagnosed Parkinson’s disease: A case-control study
Owolabi, L. F., Samaila, A., & Sunmonu, T. (2014) · Tropical Gastroenterology · doi:10.7869/tg.221 · Cited by 19
Dysphagia in Parkinson’s Disease Improves with Vocal Augmentation
Howell, R. J., Webster, H., Kissela, E., Gustin, R. L., Kaval, F., Klaben, B. K., & Khosla, S. M. (2019) · Dysphagia · doi:10.1007/s00455-019-09982-z · Cited by 18
Investigation of urinary storage symptoms in Parkinson's disease utilizing structural MRI techniques
Roy, H., GRIFFITHS, D. J., Aziz, T. Z., Green, A. L., & Menke, R. (2019) · Neurourology and Urodynamics · doi:10.1002/nau.23976 · Cited by 18
Naranjo, C. C., Marras, C., Visanji, N. P., Cornforth, D. J., Sanchez-Rodriguez, L. M., Schüle, B., Goldman, S. M., Estévez, M., Stein, P. K., Lang, A. E., et al. (2019) · Clinical Autonomic Research · doi:10.1007/s10286-019-00632-w · Cited by 18
Forehead sympathetic skin responses in determining autonomic involvement in Parkinson’s disease
Sarıahmetoğlu, H., Soysal, A., Şen, A., Yüksel, B., Celiker, S., Ciftci-Kavaklioglu, B., & Arpacı, B. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.03.024 · Cited by 15
Peripheral Autonomic Nervous System Involvement in Gaucher-Related Parkinsonism
Lebouvier, T., Clairembault, T., Devos, D., Pallardy, A., Coron, E., Neunlist, M., & Derkinderen, P. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130333 · Cited by 14
Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals
Gatto, E. M., Etcheverry, J. L., Sanguinetti, A. C., Cesarini, M., Escobar, N. F., & Drelichman, G. I. (2016) · European Neurology · doi:10.1159/000447510 · Cited by 14
Urinary Incontinence, Incident Parkinsonism, and Parkinson’s Disease Pathology in Older Adults
Buchman, N., Leurgans, S. E., Shah, R. J., VanderHorst, V., Wilson, R. S., Bachner, Y. G., Tanné, D., Schneider, J. A., Bennett, D. A., & Buchman, A. S. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw235 · Cited by 13
Gastrointestinal complications in newly diagnosed Parkinson's disease: A case-control study.
Owolabi, L., Samaila, A. A., & Sunmonu, T. (2014) · PubMed · Cited by 10
Preserved cardiac 123I‐MIBG uptake and lack of severe autonomic dysfunction in a PARK9 patient
Kanai, K., Asahina, M., Arai, K., Tomiyama, H., Kuwabara, Y., Uchiyama, T., Sekiguchi, Y., Funayama, M., Kuwabara, S., Hattori, N., et al. (2009) · Movement Disorders · doi:10.1002/mds.22520 · Cited by 4
Cited by
Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Hamamah, S., Aghazarian, A., Nazaryan, A., Hajnal, A., & Covasa, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020436 · Cited by 307
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Harms, A. S., Ferreira, S. A., & Romero-Ramos, M. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02268-5 · Cited by 272
Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson’s Disease
Gonçalves, V. C., Cuenca-Bermejo, L., Fernandez-Villalba, E., Martin-Balbuena, S., da Silva Fernandes, M. J., Scorza, C. A., & Herrero, M.-T. (2022) · The Neuroscientist · doi:10.1177/1073858421990000 · Cited by 37
Metadata
- Authors
- Chen, Z., Li, G., & Liu, J.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 134
- Pages
- 104700
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2991891929
- Cited by
- 363
- References
- 213
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.